
Important Materials
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
Apr 17, 2025
BUSINESSWIRE
SCHEDULE 14A Kent Lake’s Definitive Proxy
Apr 17, 2025
SEC Filing
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya
Apr 07, 2025
BUSINESSWIRE
SCHEDULE 14A Preliminary Proxy
Mar 31, 2025
SEC Filing
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call
Mar 17, 2025
BUSINESSWIRE
Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences
Mar 11, 2025
BUSINESSWIRE
Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board
Mar 03, 2025
BUSINESSWIRE
Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences
Feb 18, 2025
BUSINESSWIRE
SCHEDULE 13D
Feb 07, 2025
SEC Filing